European Biotech Acquisition Corp (EBAC)


Stock Price Forecast

March 2, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading European Biotech Acquisition Corp chart...

About the Company

We do not have any company description for European Biotech Acquisition Corp at the moment.

Employees

2

Exchange

NASDAQ

$M

Total Revenue

2

Employees

$166M

Market Capitalization

65.13

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $EBAC News

Eight biotech companies you should know about in Austria

9d ago, source: labiotech

Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations ...

EBRD will provide Farmak with EUR 22 million loan for acquisition of Polish pharmaceutical company Symphar

6d ago, source: Новости Украины

The European Bank for Reconstruction and Development has decided to allocate a loan of EUR 22 million to a major ...

Illumina gets go-ahead from European Commission to part ways with Grail

6d ago, source: FierceBiotech

The European ... to the acquisition, saying that ownership of Grail could tempt Illumina into throttling back the research ...

German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline

on MSN ago, source:

Germany’s competition authority, Bundeskartellamt, cleared the planned acquisition of Cardior Pharmaceuticals GmbH by Danish ...

European Commission’s Illumina Antitrust Enforcement ‘Misinterpreted’ Regulation, Adviser to EU Top Court Says

6d ago, source:

An ECJ decision to follow its Advocate General’s advice could doom the EU antitrust watchdog’s other cases targeting mergers ...

Is This Beaten-Down Stock a Good Acquisition Target?

on MSN ago, source:

W e've seen some significant acquisitions unfold in the biotech industry in the past five years, and there are good reasons ...

Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs

3d ago, source:

Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical ...

Drugmakers race to find alternative suppliers as US cracks down on Chinese biotech

7d ago, source:

The Biosecure Act would prohibit US companies receiving federal grant money from working with four Chinese biotech companies, ...

7 A-Rated Aggressive Biotech Stocks to Bet On in 2024

6d ago, source:

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The best biotech stocks to buy are in companies that put a lot ...

Vertex Pharmaceuticals: Alpine Accelerates Aspiration To Become Biotech Powerhouse

6d ago, source:

Vertex Pharmaceuticals' acquisition of Alpine Immune Sciences has the potential to boost their value and expand their ...

Flora Growth Corp. Enters into Definitive Agreement to Acquire TruHC

2d ago, source:

Acquisition capitalizes on TruHC's strategically built German cannabis platform, including:EU-GMP processing and production licenseGDP wholesale ...

Sartorius Stedim Biotech publishes unaudited -2-

17h ago, source:

DJ Sartorius Stedim Biotech publishes unaudited first quarter results for 2024 Sartorius Stedim Biotech SA / Key word(s): Quarter Results Sartorius Stedim Biotech publishes unaudited first quarter ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...